A Real-world Registry Investigating Sirolimus-coated Balloon Versus

Status Recruiting

Clinical Trial Summary

Drug-coated balloon (DCB) angioplasty has been shown to be superior to POBA in the treatment of stenosis in AVF. This is because the very intervention used to treat underlying stenosis by POBA can induce vascular injury and accelerate intimal hyperplasia, resulting in rapid restenosis and need for repeated procedure to maintain vessel patency. The anti-proliferative drug that is coated on the surface of balloon is released to the vessel wall during balloon angioplasty and blunt the acceleration of intimal hyperplasia response, resulting in improved primary patency after angioplasty. Additionally, unlike stents, DCB does not leave a permanent structure that may impede future surgical revision. Recent randomized control trials (RCT) have shown the superiority of paclitaxel durg-coated balloon (PDCB) over POBA in the treatment of stenosis in AVFs. In a large multicenter RCT, PDCB was demonstrated to result in a 6-month target lesion primary patency of 82.2% compared to 59.5% for POBA. However, concerns had also arisen recently in the use of PDCB. In large lower limb studies involving the use of paclitaxel devices, meta-analysis by Katsanos et al had revealed increased late risk mortality in patient that are treated with PDCB or paclitaxel-coated stent. Sirolimus drug-coated balloon (SDCB) is the new generation of drug eluting balloons that are available in the market. Compared to paclitaxel, sirolimus is cytostatic in its mode of action with a high margin of safety. It has a high transfer rate to the vessel wall and effectively inhibit neointimal hyperplasia in the porcine coronary model. The effectiveness of SDCB in patients with dialysis access dysfunction has been shown in a small pilot study in AVF stenosis and AVG thrombosis. SAVE AVF registry ams to assess the efficacy and safety of SDCB vs PDCB angioplasty.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05333640
Study type	Observational [Patient Registry]
Source	Singapore General Hospital
Contact	Charyl Yap
Phone	6576 7986
Email	Charyl.yap.j.q@sgh.com.sg
Status	Recruiting
Phase
Start date	April 18, 2022
Completion date	April 30, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04848376` - Post-Market Clinical Follow-up Study of A-SPINE's Products
Recruiting	`NCT04584632` - The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery	N/A
Completed	`NCT02834806` - BIONICS Israel Trial	N/A
Recruiting	`NCT02395354` - Comparative Prospective Multicenter Randomized Study of Endoscopic Treatment of Stenosis in Crohn´s Disease	N/A
Completed	`NCT00555659` - Prospective Clinical Evaluation of the New Aegis Plate for Anterior Interbody Fusions	N/A
Withdrawn	`NCT00543348` - RCT of the Cutting Balloon Versus a High Pressure Balloon for the Treatment of Arteriovenous Fistula Stenoses	N/A
Completed	`NCT00205101` - Clinical Outcome Study of the Triad Allograft for Posterior Lumbar Fusion
Terminated	`NCT04370041` - Dokimos Plus Aortic Valve Implant in 80 Patients Diagnosed With a Heart Valve Disease and Requiring Valve Replacement	N/A
Recruiting	`NCT05053932` - Long-term Comparative Cerebrovascular Outcome After Transplantation vs Standard Care in Sickle Cell Anemia
Completed	`NCT02373852` - PMS Retrospective Study of WIRION Performance in Patients Undergoing Saphenous Vein Graft (SVG) Intervention
Completed	`NCT01970579` - Clinical Trial on Peripheral Arteries Treated With SeQuent® Please P Paclitaxel Coated Balloon Catheter	Phase 3
Completed	`NCT01873586` - OsteoStrux™ Collagen Ceramic Scaffold in Instrumented Lumbar Spine Fusion	N/A
Completed	`NCT00540813` - Paclitaxel-Eluting Balloon Angioplasty and Coroflex™-Stents in the Treatment of Bifurcated Coronary Lesions	N/A
Recruiting	`NCT00496639` - Stent vs. Angioplasty for Treatment of Thrombosed AV Grafts: Long-Term Outcomes	N/A
Terminated	`NCT00254852` - Evaluation of Radiographic and Patient Outcomes Following Lumbar Spine Fusion Using Demineralized Bone Matrix (DBM) Mixed With Autograft	N/A
Enrolling by invitation	`NCT05583305` - Prevalence and Etiologies of Intracranial Stenosis in Patients With Antiphospholipid Syndrome
Completed	`NCT02018445` - Accell Evo3™ Demineralized Bone Matrix in Instrumented Lumbar Spine Fusion	N/A
Withdrawn	`NCT03327272` - Impact of Local Steroid Application in Extreme Lateral Lumbar Interbody Fusion	Phase 3
Completed	`NCT04698512` - MAgicTouch™ Intervention Leap for Dialysis Access (MATILDA) Trial
Active, not recruiting	`NCT02428582` - Covered Stents Versus Bare-Metal Stents	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

A Real-world Registry Investigating Sirolimus-coated Balloon Versus Paclitaxel-coated Balloon Angioplasty for the Treatment of Dysfunctional Arteriovenous Fistula — SAVE AVF

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms